Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study (Q44232589)
Jump to navigation
Jump to search
scientific article published on 27 November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study |
scientific article published on 27 November 2002 |
Statements
1 reference
Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study (English)
1 reference
Pieter Sonneveld
1 reference
Henk M Lokhorst
1 reference
Bronno van der Holt
1 reference
Harry C Schouten
1 reference
Christine M Segeren
1 reference
Edo Vellenga
1 reference
Alexandra J Croockewit
1 reference
Gregor E G Verhoef
1 reference
Jan J Cornelissen
1 reference
Martijn R Schaafsma
1 reference
Marinus H J van Oers
1 reference
Pierre W Wijermans
1 reference
Wim E Fibbe
1 reference
Shulamit Wittebol
1 reference
Marinus van Marwijk Kooy
1 reference
Douwe H Biesma
1 reference
Joke W Baars
1 reference
Rosalyn Slater
1 reference
Monique M C Steijaert
1 reference
Ivon Buijt
1 reference
Dutch-Belgian Hemato-Oncology Cooperative Study Group
1 reference
27 November 2002
1 reference
Identifiers
1 reference